Stock listing
RNAZ Stock Price, News, Filings & Events — Transcode Therapeutics, Inc.
Selected listing: RNAZ · NASDAQ · USD · US
RNAZ:NASDAQ is the ticker for Transcode Therapeutics, Inc., a public company with a market capitalization of approximately $8.39 million. The company is dedicated to advancing innovative therapeutics specifically in RNA-based treatments. Recent developments and filings related to their research efforts highlight their commitment to addressing unmet medical needs in this emerging field. As the market evolves, Transcode Therapeutics continues to position itself within the biotechnology landscape.
- Ticker
- RNAZ:NASDAQ
- Asset type
- Stock
- Market cap
- $6.3M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Transcode Therapeutics, Inc. RNAZ:NASDAQ stock context
RNAZ:NASDAQ is the ticker for Transcode Therapeutics, Inc., a public company with a market capitalization of approximately $8.39 million. The company is dedicated to advancing innovative therapeutics specifically in RNA-based treatments. Recent developments and filings related to their research efforts highlight their commitment to addressing unmet medical needs in this emerging field. As the market evolves, Transcode Therapeutics continues to position itself within the biotechnology landscape.
Research Transcode Therapeutics, Inc.
Transcode Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for RNAZ:NASDAQ.
Transcode Therapeutics, Inc. company profile
View the public company page for Transcode Therapeutics, Inc. on 6ix.
Transcode Therapeutics, Inc. news
Read company news and market updates connected to Transcode Therapeutics, Inc..
Transcode Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Transcode Therapeutics, Inc..